Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SAFESPACE GLOBAL CORPORATION (SSGC)

  • Business News
  • June 01, 2026, 23:21 UTC
  • 3
  • 1 comments

SafeSpace Global Expands AI-powered Physical Safety Footprint Through Successful Integration with 911inform, the Nations Leading Emergency Response Platform

Market reaction Comment Full text

GENERAL MILLS INC (GIS)

  • Business News
  • June 01, 2026, 23:00 UTC
  • 3
  • 1 comments

General Mills to Sell Häagen-Dazs Shops in Mainland China to Investor Group Including Ningji

Market reaction Comment Full text

NEXTRACKER INC. (NXT)

  • Business News
  • June 01, 2026, 23:00 UTC
  • 2
  • 1 comments

GameChange Energy to Vigorously Defend Patent Infringement Allegations by Nextpower

Market reaction Comment Full text

LUCID GROUP, INC. (LCID)

  • Business News
  • June 01, 2026, 23:00 UTC
  • 3
  • 1 comments

INVESTOR ALERT: Securities Class Action Filed Against Lucid Group, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

Market reaction Comment Full text

FULGENT GENETICS, INC. (FLGT)

  • Business News
  • June 01, 2026, 23:00 UTC
  • 3
  • 1 comments

Fulgent Presents Updated FID-007 Data at ASCO 2026

Market reaction Comment Full text

COCA COLA CO (KO)

  • Business News
  • June 01, 2026, 23:00 UTC
  • 3
  • 1 comments

The Coca-Cola Company Exploring Potential Public Listing in India for Hindustan Coca-Cola Holdings Pvt. Ltd., Parent Company of its Largest Bottler in India

Market reaction Comment Full text

Clinuvel Pharmaceuticals Ltd. (CLVLF)

  • Business News
  • June 01, 2026, 23:00 UTC
  • 2
  • 1 comments

CLINUVEL non-deal roadshow presentation deck

Market reaction Comment Full text

AIRPORT CITY LTD (ARPT)

  • Business News
  • June 01, 2026, 22:59 UTC
  • 5
  • 1 comments

Results of institutional tender

Market reaction Comment Full text

U S GLOBAL INVESTORS INC (GROW)

  • Business News
  • June 01, 2026, 22:46 UTC
  • 7
  • 1 comments

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

Market reaction Comment Full text

VERTEX PHARMACEUTICALS INC / MA (VRTX)

  • Business News
  • June 01, 2026, 22:30 UTC
  • 7
  • 1 comments

Clinical trial NCT06619860 updates: 1. completion date: 2026-05-30 → 2027-04-22 2. primary completion date: 2026-04-30 → 2027-03-25

Market reaction Comment Full text
  • Previous
  • 1029
  • 1030
  • 1031
  • 1032
  • 1033
  • Next

Search

News categories

  • Technical Exchange News(13295)
  • Event(6229)
  • SEC News(337452)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(187627)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin